A Study of Surufatinib Plus Sintilimab in Patients With Advanced Solid Tumor

Clinical trial NCT04427774 · TERMINATED

Trial details

NCT number: NCT04427774
Sponsor: Innovent Biologics (Suzhou) Co. Ltd.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced or Metastatic Solid Tumors

Start date: 2020-06-29
Primary completion: 2021-02-08
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.